Stock Update (NYSE:HCP): Harwood Feffer LLP Announces Investigation of HCP, Inc.

[PR Newswire] – NEW YORK, May 10, 2016 /PRNewswire/ — Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of HCP, Inc. (“HCP” or the “Company”) (NYSE: … Read more on this. HCP, Inc. (HCP) , with a current market cap of $16.20B, started the session at $36.23. Today, shares have traded between $34.08 and $36.39 per share with its 52-week range being $25.11 to $40.90. Priced at 12.99x this year’s forecasted earnings, HCP shares are relatively inexpensive compared to the industry’s 17.90x forward p/e ratio. The company pays shareholders $2.30 per share in dividend income per year, for a current yield of 6.66%. Consensus earnings for the current quarter by the 16 sell-side analysts covering the stock is an estimate of $0.68 per share, which would be $0.11 worse than the year-ago quarter and a $0.11 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $2.77 would be a $0.39 worse when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $628.29 Million. If reported, that would be a 3.42% increase over the year-ago quarter. More recently, Jefferies upgraded HCP from Underperform to Hold (May 10, 2016). Previously, UBS downgraded HCP from Buy to Neutral. The average price target for HCP shares by the analysts covering it is $29.92, which is 17.42% below where the stock opened. See more in (NYSE:HCP) Similar Articles: Stock Update (NASDAQ:ESRX): Harwood Feffer LLP Announces Investigation of Express Scripts Holding Company Company Update (NYSE:HCP): HCP Declares Quarterly Cash Dividend on Common Stock Market Update (NYSE:FCX): Harwood Feffer LLP Announces Investigation of Freeport-McMoRan Inc.